News Feature Channel: Weight Loss

Is Weight Loss Surgery right for me?

Hackensack Meridian Health — Fri, 08 Nov 2024 13:20:00 EST

As year-end insurance deductibles are met and plans are made for a healthy start to the new year, many people choose to have elective health procedures such as bariatric surgery around this time. If considering this type of weight loss surgery, what should you keep in mind? A Hackensack Meridian Health expert shares some tips.

Weight Loss Interventions Associated with Improvements in Several Symptoms of PCOS

American College of Physicians (ACP) — Mon, 04 Nov 2024 17:00:00 EST

A systematic review of randomized controlled trials (RCTs) found that weight-loss interventions were associated with improvements in some polycystic ovary syndrome (PCOS) symptoms, including improvement in menstrual frequency, and could be considered a routine treatment option for patients with PCOS.

Sustained Remission of Diabetes and Other Obesity-Related Conditions Found a Decade After Weight Loss Surgery in Adolescence

Ann and Robert H. Lurie Children's Hospital of Chicago — Wed, 30 Oct 2024 17:00:00 EST

Ten years after undergoing bariatric surgery as teens, over half of study participants demonstrated not only sustained weight loss, but also resolution of obesity-related conditions, such as type 2 diabetes, high blood pressure and high cholesterol, according to the report published in the New England Journal of Medicine.

Keto Diet, Supplements May Restart Stalled Menstruation

Ohio State University — Wed, 30 Oct 2024 12:20:52 EST

Increasing ketones in the blood through a keto diet or supplements may help put irregular menstrual cycles back on schedule or even restart a period that appears to have stalled for good, new research suggests.

Popular Diabetes and Weight-Loss Drug May Reduce Risk of Alzheimer's Disease

Case Western Reserve University — Thu, 24 Oct 2024 07:00:00 EST

Researchers at the Case Western Reserve School of Medicine have found that semaglutide may lower the risk of Alzheimer's disease in people with type 2 diabetes (T2D).

Can Small Bursts of Activity Throughout the Day Decrease Chronic Pain?

Wake Forest University School of Medicine — Wed, 23 Oct 2024 16:10:52 EST

Setting out to prove that movement indeed is medicine for older adults with chronic knee and hip pain, Wake Forest University researchers have received a $5.7 grant from the National Institutes of Health (NIH) to conduct a five-year study.

ACSM Announces Worldwide Fitness Trends for 2025

American College of Sports Medicine (ACSM) — Tue, 22 Oct 2024 07:30:30 EST

Technology applications in the fitness industry continue to build momentum as Wearable Technology, Mobile Exercise Apps and Data-Driven Training Technology all appear in the top 10 of the 2025 ACSM Worldwide Fitness Trends. The report was published today by the American College of Sports Medicine in its November/December issue of ACSM's Health & Fitness Journal(r).

Whooping Cough Five Times Higher

Texas Tech University Health Sciences Center El Paso — Mon, 21 Oct 2024 11:00:03 EST

Bariatric Surgery Is More Cost Effective Than Newer Weight Loss Drugs Alone

American College of Surgeons (ACS) — Fri, 18 Oct 2024 08:00:00 EST

Newer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according to a study presented at the American College of Surgeons (ACS) Clinical Congress 2024 in San Francisco, California. Further, a second study presented at the meeting found that this increasingly popular class of weight loss drugs, called glucagon-like peptide-1 receptor agonists, or GLP-1 RA, appears safe and may be a novel approach to treating obesity when used before bariatric surgery.

Experts Debate Pharmacologic Management of a Patient with Obesity

American College of Physicians (ACP) — Mon, 07 Oct 2024 17:00:00 EST

In a new Annals "Beyond the Guidelines" feature, two internal medicine physicians discuss treatment for a patient with obesity and prediabetes in the context of American Gastroenterological Association (AGA) evidence-based recommendations for the pharmacologic management of obesity in adults.

PCORI Awards $37 Million To Accelerate Implementation of Evidence-Based Health Research

Patient-Centered Outcomes Research Institute (PCORI) — Wed, 02 Oct 2024 11:05:44 EST

The Patient-Centered Outcomes Research Institute (PCORI) today announced $37 million in funding awards through its Health Systems Implementation Initiative (HSII). These awards will support 25 projects implementing PCORI-funded comparative clinical effectiveness research (CER) findings in participating HSII health systems.

Popular Diabetes and Weight-Loss Drug Associated with Lower Opioid Overdose Risk

Case Western Reserve University — Wed, 25 Sep 2024 11:00:00 EST

Case Western Reserve University School of Medicine identifies a potential new approach to address the opioid overdose epidemic--which has devastated families and communities nationally. Semaglutide was found to lower opioid overdoses in people with opioid-use disorder (OUD) and type 2 diabetes (T2D).

Mount Sinai Health System and Noom Partner to Help Patients Achieve Healthy Weight Loss Outcomes With an On-Demand Digital Health Platform

Mount Sinai Health System — Wed, 25 Sep 2024 08:00:48 EST

Mount Sinai Health System, a leading health system in the United States and one of the largest in the New York City area, and Noom, the leading digital health care company committed to chronic disease prevention and empowering people to live better and healthier lives, have partnered to provide patients with a whole-person approach to healthy, long-lasting weight loss.

Proteins Prohibitins Can Become New Targets for Drugs From Obesity

Scientific Project Lomonosov — Tue, 24 Sep 2024 07:05:28 EST

Scientists from Immanuel Kant Baltic Federal University analyzed scientific works dedicated to the role of proteins prohibitins in the development of obesity. It turned out that these proteins promote development of inflammation both in separate cells and the whole organism. This happens because prohibitins stimulate emission of anti-inflammatory substances by immune cells, and also participate in destruction of mitochondria damaged during oxidative stress. Obtained information points to the fact that prohibitins can become targets for medicine aimed at struggle with obesity consequences. Results of the research are published in the magazine Frontiers in Molecular Biosciences.

The Heart of the Question: Who Can Get Medicare-Covered Weight Loss Medicine?

Michigan Medicine - University of Michigan — Mon, 23 Sep 2024 17:30:26 EST

Wegovy (semaglutide) now has Medicare approval for coverage among people with obesity and cardiovascular disease but no diabetes; a study looks at what level of risk might make someone eligible.

American Society of Nephrology Releases Kidney Health Guidance on the Management of Obesity in Persons with Kidney Diseases

American Society of Nephrology (ASN) — Wed, 18 Sep 2024 12:00:00 EST

To promote high-quality, person-directed care across the spectrum of kidney health and diseases the American Society of Nephrology (ASN) is releasing its inaugural Kidney Health Guidance (KHG) on the Management of Obesity in Persons Living with Kidney Diseases in the Journal of the American Society of Nephrology (JASN) on September 18, 2024.

Endurance Exercise without Weight Loss May Reduce Body Fat

American Physiological Society (APS) — Wed, 18 Sep 2024 07:00:17 EST

Participating in a high volume of exercise over a short period of time, such as cycling hundreds of miles in a few days, could reduce body fat levels without weight loss. The first-of-its-kind study is published ahead of print in the American Journal of Physiology-Endocrinology and Metabolism and has been chosen as an APSselect article for September.

Research Assesses Impact of Weight Loss and Blood Sugar Control in Type 2 Diabetes

Cleveland Clinic — Tue, 17 Sep 2024 09:05:48 EST

Survey Shows 25% of Adults Consider Weight Loss Drug Use Without Prescription

Ohio State University Wexner Medical Center — Tue, 17 Sep 2024 00:05:00 EST

A new national survey from The Ohio State University Wexner Medical Center reveals 1 in 4 (25%) of 1,006 adults surveyed would consider using an injectable weight loss medication without consulting their doctor.

Cleveland Clinic Study Identifies Key Factors That Can Impact Long-Term Weight Loss in Patients with Obesity Who Were Prescribed GLP-1 RA Medications

Cleveland Clinic — Fri, 13 Sep 2024 11:00:00 EST

Cleveland Clinic Study Identifies Key Factors That Can Impact Long-Term Weight Loss in Patients with Obesity Who Were Prescribed GLP-1 RA Medications